600671 天目药业
已收盘 01-27 15:00:00
资讯
新帖
简况
每周股票复盘：天目药业（600671）三日涨幅偏离超20%
证券之星 · 01-25 02:04
每周股票复盘：天目药业（600671）三日涨幅偏离超20%
股市必读：天目药业（600671）1月22日收盘跌9.69%，主力净流出1017.96万元
证券之星 · 01-23
股市必读：天目药业（600671）1月22日收盘跌9.69%，主力净流出1017.96万元
1月22日天目药业（600671）龙虎榜数据：游资小鳄鱼上榜
证券之星 · 01-22
1月22日天目药业（600671）龙虎榜数据：游资小鳄鱼上榜
异动快报：天目药业（600671）1月22日14点39分触及跌停板
证券之星 · 01-22
异动快报：天目药业（600671）1月22日14点39分触及跌停板
天目药业最新公告：公司目前生产经营活动正常不存在应披露而未披露的重大事项
证券之星 · 01-21
天目药业最新公告：公司目前生产经营活动正常不存在应披露而未披露的重大事项
1月21日天目药业（600671）龙虎榜数据：游资瑞鹤仙上榜
证券之星 · 01-21
1月21日天目药业（600671）龙虎榜数据：游资瑞鹤仙上榜
异动快报：天目药业（600671）1月19日9点49分触及涨停板
证券之星 · 01-19
异动快报：天目药业（600671）1月19日9点49分触及涨停板
每周股票复盘：天目药业（600671）股东户数较上期减少6.0户
证券之星 · 01-18
每周股票复盘：天目药业（600671）股东户数较上期减少6.0户
每周股票复盘：天目药业（600671）股东会通过续聘会计师事务所议案
证券之星 · 2025-12-28
每周股票复盘：天目药业（600671）股东会通过续聘会计师事务所议案
天目药业（600671）披露全资子公司收到药品再注册批准通知书，12月18日股价上涨3.16%
证券之星 · 2025-12-18
天目药业（600671）披露全资子公司收到药品再注册批准通知书，12月18日股价上涨3.16%
天目药业（600671）披露拟续聘2025年度审计机构，12月15日股价上涨1.68%
证券之星 · 2025-12-15
天目药业（600671）披露拟续聘2025年度审计机构，12月15日股价上涨1.68%
天目药业（600671）披露召开2025年第四次临时股东会通知，12月05日股价上涨1.89%
证券之星 · 2025-12-05
天目药业（600671）披露召开2025年第四次临时股东会通知，12月05日股价上涨1.89%
每周股票复盘：天目药业（600671）公司及子公担保余额达17,525.04万元
证券之星 · 2025-11-16
每周股票复盘：天目药业（600671）公司及子公担保余额达17,525.04万元
天目药业（600671）披露为子公司提供担保及子公司为公司提供担保的进展公告，11月11日股价上涨0.96%
证券之星 · 2025-11-11
天目药业（600671）披露为子公司提供担保及子公司为公司提供担保的进展公告，11月11日股价上涨0.96%
天目药业（600671）披露子公司取得换发后的《药品生产许可证》，11月05日股价下跌1.84%
证券之星 · 2025-11-05
天目药业（600671）披露子公司取得换发后的《药品生产许可证》，11月05日股价下跌1.84%
天目药业（600671）披露子公司取得换发后的《药品生产许可证》，11月03日股价上涨1.48%
证券之星 · 2025-11-03
天目药业（600671）披露子公司取得换发后的《药品生产许可证》，11月03日股价上涨1.48%
每周股票复盘：天目药业（600671）股东户数降6.91%，前三季净利增484.48%
证券之星 · 2025-11-02
每周股票复盘：天目药业（600671）股东户数降6.91%，前三季净利增484.48%
天目药业(600671.SH)：前三季度净利润1420.88万元
中金财经 · 2025-10-28
天目药业(600671.SH)：前三季度净利润1420.88万元
股市必读：天目药业（600671）10月17日收盘跌5.3%，主力净流入1999.38万元
证券之星 · 2025-10-20
股市必读：天目药业（600671）10月17日收盘跌5.3%，主力净流入1999.38万元
天目药业（600671）披露上半年业绩扭亏为盈，9月29日股价下跌0.27%
证券之星 · 2025-09-29
天目药业（600671）披露上半年业绩扭亏为盈，9月29日股价下跌0.27%
加载更多
公司概况
公司名称：
杭州天目山药业股份有限公司
所属行业：
医药制造业
上市日期：
1993-08-23
主营业务：
杭州天目山药业股份有限公司的主营业务是医药研发、药品流通、医技培训服务、器械销售及大健康板块的生产及销售。公司的主要产品是医药制造、药品流通、医疗培训和大健康等。
发行价格：
1.00
{"stockData":{"symbol":"600671","market":"SH","secType":"STK","nameCN":"天目药业","latestPrice":19.11,"timestamp":1769497200000,"preClose":19.05,"halted":0,"volume":5088808,"delay":0,"changeRate":0.0031,"floatShares":122000000,"shares":122000000,"eps":0.2723,"marketStatus":"已收盘","change":0.06,"latestTime":"01-27 15:00:00","open":19.27,"high":19.29,"low":18.62,"amount":96471800,"amplitude":0.0352,"askPrice":19.12,"askSize":65,"bidPrice":19.11,"bidSize":17,"shortable":0,"etf":0,"ttmEps":0.2723,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1769563800000},"marketStatusCode":5,"adr":0,"adjPreClose":19.05,"symbolType":"stock","openAndCloseTimeList":[[1769477400000,1769484600000],[1769490000000,1769497200000]],"highLimit":20.96,"lowLimit":17.15,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":121778885,"isCdr":false,"pbRate":34.84,"roa":"--","peRate":70.179949,"roe":"23.89%","epsLYR":0.1252,"committee":0.423163,"marketValue":2327000000,"turnoverRate":0.0418,"status":0,"floatMarketCap":2326000000},"requestUrl":"/m/hq/s/600671","defaultTab":"news","newsList":[{"id":"2606340482","title":"每周股票复盘：天目药业（600671）三日涨幅偏离超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606340482","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606340482?lang=zh_cn&edition=full","pubTime":"2026-01-25 02:04","pubTimestamp":1769277855,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，天目药业报收于19.57元，较上周的18.41元上涨6.3%。本周，天目药业1月22日盘中最高价报22.8元，股价触及近一年最高点。来自公司公告汇总：天目药业股票连续三日收盘价涨幅偏离值累计超过20%，构成异常波动。沪深交易所2026年1月22日公布的交易公开信息显示，天目药业因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500000549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0086","600671","BK0239"],"gpt_icon":0},{"id":"2605416337","title":"股市必读：天目药业（600671）1月22日收盘跌9.69%，主力净流出1017.96万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605416337","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605416337?lang=zh_cn&edition=full","pubTime":"2026-01-23 01:14","pubTimestamp":1769102092,"startTime":"0","endTime":"0","summary":"截至2026年1月22日收盘，天目药业报收于20.13元，下跌9.69%，换手率11.11%，成交量13.52万手，成交额2.8亿元。交易信息汇总股价提醒1月22日天目药业收盘报20.13元，跌9.69%，当日成交1352.3万元。龙虎榜上榜沪深交易所2026年1月22日公布的交易公开信息显示，天目药业因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300000645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600671","BK0086","BK0174","BK0239"],"gpt_icon":0},{"id":"2605638464","title":"1月22日天目药业（600671）龙虎榜数据：游资小鳄鱼上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2605638464","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605638464?lang=zh_cn&edition=full","pubTime":"2026-01-22 17:41","pubTimestamp":1769074917,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年1月22日公布的交易公开信息显示，天目药业因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2026年1月22日收盘，天目药业报收于20.13元，下跌9.69%，换手率11.11%，成交量13.52万手，成交额2.8亿元。从龙虎榜公布的当日买卖数据来看，小鳄鱼等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200029197.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0086","BK0239","600671"],"gpt_icon":0},{"id":"2605571234","title":"异动快报：天目药业（600671）1月22日14点39分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2605571234","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605571234?lang=zh_cn&edition=full","pubTime":"2026-01-22 14:40","pubTimestamp":1769064035,"startTime":"0","endTime":"0","summary":"证券之星1月22日盘中消息，14点39分天目药业触及跌停板。其所属行业中药目前上涨。领涨股为*ST长药。该股为食品，养老产业，保健品概念热股，当日食品概念上涨0.69%，养老产业概念上涨0.59%，保健品概念上涨0.38%。1月21日的资金流向数据方面，主力资金净流出1017.96万元，占总成交额3.6%，游资资金净流出675.1万元，占总成交额2.39%，散户资金净流入1693.06万元，占总成交额5.99%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200018972.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0239","BK0086","600671"],"gpt_icon":0},{"id":"2605031041","title":"天目药业最新公告：公司目前生产经营活动正常不存在应披露而未披露的重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2605031041","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605031041?lang=zh_cn&edition=full","pubTime":"2026-01-21 18:31","pubTimestamp":1768991489,"startTime":"0","endTime":"0","summary":"天目药业(600671.SH)公告称，公司股票连续三个交易日内收盘价格涨幅偏离值累计超过20%，属于股票交易异常波动情形。经自查和控股股东函证核实，公司及控股股东不存在应披露而未披露的重大事项。公司目前生产经营活动正常，内部生产经营秩序正常，市场环境及行业政策未发生重大调整。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100031988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0239","BK0174","600671"],"gpt_icon":0},{"id":"2605817098","title":"1月21日天目药业（600671）龙虎榜数据：游资瑞鹤仙上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2605817098","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605817098?lang=zh_cn&edition=full","pubTime":"2026-01-21 17:39","pubTimestamp":1768988392,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年1月21日公布的交易公开信息显示，天目药业因非ST、*ST和S证券连续三个交易日内收盘价格涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年1月21日收盘，天目药业报收于22.29元，上涨8.47%，换手率10.52%，成交量12.81万手，成交额2.82亿元。从龙虎榜公布的三日买卖数据来看，瑞鹤仙等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100029524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0174","600671","BK0086"],"gpt_icon":0},{"id":"2604886906","title":"异动快报：天目药业（600671）1月19日9点49分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2604886906","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604886906?lang=zh_cn&edition=full","pubTime":"2026-01-19 09:50","pubTimestamp":1768787441,"startTime":"0","endTime":"0","summary":"证券之星1月19日盘中消息，9点49分天目药业（600671）触及涨停板。其所属行业中药目前上涨。领涨股为天目药业。该股为食品，中药，医药概念热股，当日食品概念上涨0.43%，中药概念上涨0.15%，医药概念上涨0.11%。1月16日的资金流向数据方面，主力资金净流入388.9万元，占总成交额5.24%，游资资金净流入44.22万元，占总成交额0.6%，散户资金净流出433.13万元，占总成交额5.84%。近5日资金流向一览见下表：天目药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900004672.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600671","BK0174","BK0086"],"gpt_icon":0},{"id":"2604925596","title":"每周股票复盘：天目药业（600671）股东户数较上期减少6.0户","url":"https://stock-news.laohu8.com/highlight/detail?id=2604925596","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604925596?lang=zh_cn&edition=full","pubTime":"2026-01-18 03:50","pubTimestamp":1768679414,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，天目药业报收于18.41元，较上周的17.47元上涨5.38%。本周，天目药业1月16日盘中最高价报18.66元。1月14日盘中最低价报17.25元。天目药业当前最新总市值22.42亿元，在中药板块市值排名65/67，在两市A股市值排名5037/5183。户均持股数量由上期的1.26万股增加至1.26万股，户均持股市值为21.96万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800001118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","600671","BK0086","BK0239"],"gpt_icon":0},{"id":"2594242995","title":"每周股票复盘：天目药业（600671）股东会通过续聘会计师事务所议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2594242995","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594242995?lang=zh_cn&edition=full","pubTime":"2025-12-28 03:59","pubTimestamp":1766865547,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，天目药业报收于17.08元，较上周的17.51元下跌2.46%。本周关注点公司公告汇总：股东会审议通过《关于续聘会计师事务所的议案》，同意股份数占出席会议股东所持有效表决权的98.9395%。上海泽昌律师事务所对本次会议进行见证，认为会议召集、召开程序及表决结果合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800000962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0174","600671","BK0086"],"gpt_icon":0},{"id":"2592902219","title":"天目药业（600671）披露全资子公司收到药品再注册批准通知书，12月18日股价上涨3.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592902219","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592902219?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:39","pubTimestamp":1766068757,"startTime":"0","endTime":"0","summary":"截至2025年12月18日收盘，天目药业报收于17.65元，较前一交易日上涨3.16%，最新总市值为21.49亿元。公司近日发布公告称，其全资子公司黄山市天目药业有限公司收到安徽省药品监督管理局核准签发的《药品再注册批准通知书》，涉及知柏地黄丸、舒筋活血片、桂附地黄丸、归脾丸、安神补心丸、杜仲颗粒、黄连上清片等7个药品，药品批准文号有效期均延长至2030年11月。上述药品恢复生产前需经现场检查并抽验合格后方可上市销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800039216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600671","BK0086","BK0239","BK0174"],"gpt_icon":0},{"id":"2591642100","title":"天目药业（600671）披露拟续聘2025年度审计机构，12月15日股价上涨1.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591642100","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591642100?lang=zh_cn&edition=full","pubTime":"2025-12-15 22:30","pubTimestamp":1765809030,"startTime":"0","endTime":"0","summary":"截至2025年12月15日收盘，天目药业报收于16.92元，较前一交易日上涨1.68%，最新总市值为20.6亿元。该股当日开盘16.62元，最高17.05元，最低16.47元，成交额达3123.7万元，换手率为1.52%。公司近日发布公告称，拟续聘尤尼泰振青会计师事务所为公司2025年度财务报告和内部控制审计机构，聘期一年。该事项已经公司第十二届董事会第十七次会议审议通过，2025年度预计审计费用不超过83万元，其中财务报告审计费用48万元，内部控制审计费用35万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500036062.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0174","600671","BK0086"],"gpt_icon":0},{"id":"2589312813","title":"天目药业（600671）披露召开2025年第四次临时股东会通知，12月05日股价上涨1.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589312813","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589312813?lang=zh_cn&edition=full","pubTime":"2025-12-05 22:24","pubTimestamp":1764944673,"startTime":"0","endTime":"0","summary":"截至2025年12月5日收盘，天目药业报收于17.23元，较前一交易日上涨1.89%，最新总市值为20.98亿元。该股当日开盘16.78元，最高17.38元，最低16.78元，成交额达3395.56万元，换手率为1.63%。公司近日发布公告称，杭州天目山药业股份有限公司将于2025年12月22日召开2025年第四次临时股东会，会议采取现场与网络投票相结合方式，网络投票通过上海证券交易所系统进行。股权登记日为2025年12月16日，A股股东可参与投票。股东可于12月19日前通过电子邮件完成登记。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500040632.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0086","BK0239","600671"],"gpt_icon":0},{"id":"2583517186","title":"每周股票复盘：天目药业（600671）公司及子公担保余额达17,525.04万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583517186","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583517186?lang=zh_cn&edition=full","pubTime":"2025-11-16 04:02","pubTimestamp":1763236938,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，天目药业报收于18.95元，较上周的18.81元上涨0.74%。本周，天目药业11月11日盘中最高价报19.4元。天目药业当前最新总市值23.08亿元，在中药板块市值排名66/67，在两市A股市值排名5021/5165。本次担保在2025年度预计担保额度内，无需另行履行审议程序。截至公告日，公司及子公司实际对外担保余额为17,525.04万元，占最近一期经审计净资产的334.55%，无逾期担保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600001090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0086","600671","BK0239"],"gpt_icon":0},{"id":"2582360326","title":"天目药业（600671）披露为子公司提供担保及子公司为公司提供担保的进展公告，11月11日股价上涨0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582360326","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582360326?lang=zh_cn&edition=full","pubTime":"2025-11-11 22:51","pubTimestamp":1762872682,"startTime":"0","endTime":"0","summary":"截至2025年11月11日收盘，天目药业报收于18.98元，较前一交易日上涨0.96%，最新总市值为23.11亿元。近日，杭州天目山药业股份有限公司发布关于为子公司提供担保及子公司为公司提供担保的进展公告。本次担保在2025年度预计担保额度内，无需另行履行审议程序。截至公告日，公司及子公司实际对外担保余额为17,525.04万元，占最近一期经审计净资产的334.55%，无逾期担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100041325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0174","600671","BK0086"],"gpt_icon":0},{"id":"2581877643","title":"天目药业（600671）披露子公司取得换发后的《药品生产许可证》，11月05日股价下跌1.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581877643","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581877643?lang=zh_cn&edition=full","pubTime":"2025-11-05 22:36","pubTimestamp":1762353384,"startTime":"0","endTime":"0","summary":"截至2025年11月5日收盘，天目药业报收于18.7元，较前一交易日下跌1.84%，最新总市值为22.77亿元。该股当日开盘18.86元，最高19.05元，最低18.58元，成交额达4428.61万元，换手率为1.94%。公司近日发布公告称，其子公司黄山天目薄荷药业有限公司收到安徽省药品监督管理局换发的《药品生产许可证》。本次换证系原证即将到期，新证取得保障了子公司正常生产经营，不会对公司经营业绩产生重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500040870.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600671","BK0086","BK0239","BK0174"],"gpt_icon":0},{"id":"2580214730","title":"天目药业（600671）披露子公司取得换发后的《药品生产许可证》，11月03日股价上涨1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580214730","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580214730?lang=zh_cn&edition=full","pubTime":"2025-11-03 22:50","pubTimestamp":1762181432,"startTime":"0","endTime":"0","summary":"截至2025年11月3日收盘，天目药业报收于19.15元，较前一交易日上涨1.48%，最新总市值为23.32亿元。该股当日开盘19.05元，最高19.18元，最低18.88元，成交额达4084.7万元，换手率为1.76%。公司近日发布公告称，其全资子公司黄山市天目药业有限公司收到安徽省药品监督管理局换发的《药品生产许可证》，有效期至2030年12月31日。本次换发系原证到期换发，确保黄山天目正常生产经营，不会对公司经营业绩产生重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300036413.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600671","BK0174","BK0239","BK0086"],"gpt_icon":0},{"id":"2580093405","title":"每周股票复盘：天目药业（600671）股东户数降6.91%，前三季净利增484.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580093405","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580093405?lang=zh_cn&edition=full","pubTime":"2025-11-02 10:49","pubTimestamp":1762051746,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，天目药业报收于18.87元，较上周的19.28元下跌2.13%。业绩披露要点财务报告天目药业2025年三季报显示，公司主营收入1.59亿元，同比上升27.48%；归母净利润1420.88万元，同比上升484.48%；扣非净利润1088.3万元，同比上升238.38%。公司公告汇总杭州天目山药业股份有限公司2025年第三季度报告营业收入：本报告期55,343,038.75元，同比减少15.03%；年初至报告期末158,940,412.66元，同比增加27.48%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200002468.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0239","BK0086","600671"],"gpt_icon":0},{"id":"2578495485","title":"天目药业(600671.SH)：前三季度净利润1420.88万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578495485","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578495485?lang=zh_cn&edition=full","pubTime":"2025-10-28 20:27","pubTimestamp":1761654424,"startTime":"0","endTime":"0","summary":"格隆汇10月28日丨天目药业(600671.SH)发布三季报，2025年前三季度实现营业总收入1.59亿元，同比增长27.48%；归属母公司股东净利润1420.88万元，上年同期亏损369.55万元；基本每股收益为0.1167元。\r\n\r\n \r\n\r\n 【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251028/31745061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["600671"],"gpt_icon":0},{"id":"2576070904","title":"股市必读：天目药业（600671）10月17日收盘跌5.3%，主力净流入1999.38万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576070904","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576070904?lang=zh_cn&edition=full","pubTime":"2025-10-20 02:06","pubTimestamp":1760897173,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，天目药业报收于18.4元，下跌5.3%，换手率9.87%，成交量12.01万手，成交额2.2亿元。交易信息汇总股价提醒10月17日天目药业收盘报18.4元，跌5.3%，当日成交1200.92万元。该股已连续2日下跌，近5个交易日中有2日跌幅超5%。前10个交易日主力资金累计净流出669.7万元，期间股价累计下跌0.55%。资金流向10月17日主力资金净流入1999.38万元，占总成交额9.1%；游资资金净流出409.33万元，占总成交额1.86%；散户资金净流出1590.05万元，占总成交额7.24%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000000802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","600671","BK0086","BK0239"],"gpt_icon":0},{"id":"2571389877","title":"天目药业（600671）披露上半年业绩扭亏为盈，9月29日股价下跌0.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571389877","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571389877?lang=zh_cn&edition=full","pubTime":"2025-09-29 17:42","pubTimestamp":1759138955,"startTime":"0","endTime":"0","summary":"截至2025年9月29日收盘，天目药业报收于18.26元，较前一交易日下跌0.27%，最新总市值为22.24亿元。截至2025年6月末，应收账款余额为1.29亿元，计提减值准备1,525.65万元，其中本期计提约202.48万元。前五大应收账款客户中部分为关联方，回款情况正常。公司表示，应收账款增长系业务扩张所致，相关风险可控。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900024489.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0239","BK0174","600671"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1769497607017,"stockEarnings":[{"period":"1week","weight":-0.0593},{"period":"1month","weight":0.1153},{"period":"3month","weight":-0.0251},{"period":"6month","weight":0.3463},{"period":"1year","weight":1.1003},{"period":"ytd","weight":0.1005}],"compareEarnings":[{"period":"1week","weight":0.0045},{"period":"1month","weight":0.0426},{"period":"3month","weight":0.0362},{"period":"6month","weight":0.143},{"period":"1year","weight":0.2705},{"period":"ytd","weight":0.0413}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"杭州天目山药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"9687人(较上一季度减少0.06%)","perCapita":"12565股","listingDate":"1993-08-23","address":"浙江省杭州市临安区锦南街道上杨路18号","registeredCapital":"12177万元","survey":" 杭州天目山药业股份有限公司的主营业务是医药研发、药品流通、医技培训服务、器械销售及大健康板块的生产及销售。公司的主要产品是医药制造、药品流通、医疗培训和大健康等。","listedPrice":1},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"天目药业(600671)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供天目药业(600671)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"天目药业,600671,天目药业股票,天目药业股票老虎,天目药业股票老虎国际,天目药业行情,天目药业股票行情,天目药业股价,天目药业股市,天目药业股票价格,天目药业股票交易,天目药业股票购买,天目药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"天目药业(600671)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供天目药业(600671)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}